Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Adjuvant therapy after radical trachelectomy for stage I cervical cancer.

Hazell SZ, Stone RL, Lin JY, Viswanathan AN.

Gynecol Oncol Rep. 2018 May 5;25:15-18. doi: 10.1016/j.gore.2018.05.001. eCollection 2018 Aug.

2.

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.

Wedge DC, Gundem G, Mitchell T, Woodcock DJ, Martincorena I, Ghori M, Zamora J, Butler A, Whitaker H, Kote-Jarai Z, Alexandrov LB, Van Loo P, Massie CE, Dentro S, Warren AY, Verrill C, Berney DM, Dennis N, Merson S, Hawkins S, Howat W, Lu YJ, Lambert A, Kay J, Kremeyer B, Karaszi K, Luxton H, Camacho N, Marsden L, Edwards S, Matthews L, Bo V, Leongamornlert D, McLaren S, Ng A, Yu Y, Zhang H, Dadaev T, Thomas S, Easton DF, Ahmed M, Bancroft E, Fisher C, Livni N, Nicol D, Tavaré S, Gill P, Greenman C, Khoo V, Van As N, Kumar P, Ogden C, Cahill D, Thompson A, Mayer E, Rowe E, Dudderidge T, Gnanapragasam V, Shah NC, Raine K, Jones D, Menzies A, Stebbings L, Teague J, Hazell S, Corbishley C; CAMCAP Study Group, de Bono J, Attard G, Isaacs W, Visakorpi T, Fraser M, Boutros PC, Bristow RG, Workman P, Sander C; TCGA Consortium, Hamdy FC, Futreal A, McDermott U, Al-Lazikani B, Lynch AG, Bova GS, Foster CS, Brewer DS, Neal DE, Cooper CS, Eeles RA.

Nat Genet. 2018 May;50(5):682-692. doi: 10.1038/s41588-018-0086-z. Epub 2018 Apr 16.

PMID:
29662167
3.

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.

Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez JI, Nicol D, O'Brien T, Larkin J, Horswell S, Stares M, Au L, Jamal-Hanjani M, Challacombe B, Chandra A, Hazell S, Eichler-Jonsson C, Soultati A, Chowdhury S, Rudman S, Lynch J, Fernando A, Stamp G, Nye E, Jabbar F, Spain L, Lall S, Guarch R, Falzon M, Proctor I, Pickering L, Gore M, Watkins TBK, Ward S, Stewart A, DiNatale R, Becerra MF, Reznik E, Hsieh JJ, Richmond TA, Mayhew GF, Hill SM, McNally CD, Jones C, Rosenbaum H, Stanislaw S, Burgess DL, Alexander NR, Swanton C; PEACE; TRACERx Renal Consortium.

Cell. 2018 Apr 19;173(3):581-594.e12. doi: 10.1016/j.cell.2018.03.057. Epub 2018 Apr 12.

4.

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.

Turajlic S, Xu H, Litchfield K, Rowan A, Horswell S, Chambers T, O'Brien T, Lopez JI, Watkins TBK, Nicol D, Stares M, Challacombe B, Hazell S, Chandra A, Mitchell TJ, Au L, Eichler-Jonsson C, Jabbar F, Soultati A, Chowdhury S, Rudman S, Lynch J, Fernando A, Stamp G, Nye E, Stewart A, Xing W, Smith JC, Escudero M, Huffman A, Matthews N, Elgar G, Phillimore B, Costa M, Begum S, Ward S, Salm M, Boeing S, Fisher R, Spain L, Navas C, Grönroos E, Hobor S, Sharma S, Aurangzeb I, Lall S, Polson A, Varia M, Horsfield C, Fotiadis N, Pickering L, Schwarz RF, Silva B, Herrero J, Luscombe NM, Jamal-Hanjani M, Rosenthal R, Birkbak NJ, Wilson GA, Pipek O, Ribli D, Krzystanek M, Csabai I, Szallasi Z, Gore M, McGranahan N, Van Loo P, Campbell P, Larkin J, Swanton C; TRACERx Renal Consortium.

Cell. 2018 Apr 19;173(3):595-610.e11. doi: 10.1016/j.cell.2018.03.043. Epub 2018 Apr 12.

5.

Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.

Mitchell TJ, Turajlic S, Rowan A, Nicol D, Farmery JHR, O'Brien T, Martincorena I, Tarpey P, Angelopoulos N, Yates LR, Butler AP, Raine K, Stewart GD, Challacombe B, Fernando A, Lopez JI, Hazell S, Chandra A, Chowdhury S, Rudman S, Soultati A, Stamp G, Fotiadis N, Pickering L, Au L, Spain L, Lynch J, Stares M, Teague J, Maura F, Wedge DC, Horswell S, Chambers T, Litchfield K, Xu H, Stewart A, Elaidi R, Oudard S, McGranahan N, Csabai I, Gore M, Futreal PA, Larkin J, Lynch AG, Szallasi Z, Swanton C, Campbell PJ; TRACERx Renal Consortium.

Cell. 2018 Apr 19;173(3):611-623.e17. doi: 10.1016/j.cell.2018.02.020. Epub 2018 Apr 12.

6.

Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.

Camacho N, Van Loo P, Edwards S, Kay JD, Matthews L, Haase K, Clark J, Dennis N, Thomas S, Kremeyer B, Zamora J, Butler AP, Gundem G, Merson S, Luxton H, Hawkins S, Ghori M, Marsden L, Lambert A, Karaszi K, Pelvender G, Massie CE, Kote-Jarai Z, Raine K, Jones D, Howat WJ, Hazell S, Livni N, Fisher C, Ogden C, Kumar P, Thompson A, Nicol D, Mayer E, Dudderidge T, Yu Y, Zhang H, Shah NC, Gnanapragasam VJ; CRUK-ICGC Prostate Group, Isaacs W, Visakorpi T, Hamdy F, Berney D, Verrill C, Warren AY, Wedge DC, Lynch AG, Foster CS, Lu YJ, Bova GS, Whitaker HC, McDermott U, Neal DE, Eeles R, Cooper CS, Brewer DS.

PLoS Genet. 2017 Sep 25;13(9):e1007001. doi: 10.1371/journal.pgen.1007001. eCollection 2017 Sep.

7.

Pelvic Radiation and Normal Tissue Toxicity.

Nicholas S, Chen L, Choflet A, Fader A, Guss Z, Hazell S, Song DY, Tran PT, Viswanathan AN.

Semin Radiat Oncol. 2017 Oct;27(4):358-369. doi: 10.1016/j.semradonc.2017.04.010. Review.

PMID:
28865519
8.

Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy.

Dolly SO, Migali C, Tunariu N, Della-Pepa C, Khakoo S, Hazell S, de Bono JS, Kaye SB, Banerjee S.

ESMO Open. 2017 Apr 12;2(1):e000101. doi: 10.1136/esmoopen-2016-000101. eCollection 2017.

9.

DESNT: A Poor Prognosis Category of Human Prostate Cancer.

Luca BA, Brewer DS, Edwards DR, Edwards S, Whitaker HC, Merson S, Dennis N, Cooper RA, Hazell S, Warren AY; CancerMap Group, Eeles R, Lynch AG, Ross-Adams H, Lamb AD, Neal DE, Sethia K, Mills RD, Ball RY, Curley H, Clark J, Moulton V, Cooper CS.

Eur Urol Focus. 2017 Mar 6. pii: S2405-4569(17)30025-1. doi: 10.1016/j.euf.2017.01.016. [Epub ahead of print]

10.

Doing More With Less; Are There Some 'Easy Wins' in the Management of Early Breast Cancer?

Dodwell D, Richmond A, Hazell S, Coleman R.

Clin Oncol (R Coll Radiol). 2017 Sep;29(9):550-552. doi: 10.1016/j.clon.2017.04.033. Epub 2017 May 9. No abstract available.

PMID:
28499792
11.

Separation of type and grade in cervical tumours using non-mono-exponential models of diffusion-weighted MRI.

Winfield JM, Orton MR, Collins DJ, Ind TE, Attygalle A, Hazell S, Morgan VA, deSouza NM.

Eur Radiol. 2017 Feb;27(2):627-636. doi: 10.1007/s00330-016-4417-0. Epub 2016 May 24.

12.

An Unusual Case of YWHAE-NUTM2A/B Endometrial Stromal Sarcoma With Confinement to the Endometrium and Lack of High-Grade Morphology.

Attygalle AD, Vroobel K, Wren D, Barton DP, Hazell SJ, Cin PD, Koelble K, McCluggage WG.

Int J Gynecol Pathol. 2017 Mar;36(2):165-171. doi: 10.1097/PGP.0000000000000286.

PMID:
27171540
13.

The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.

Castro E, Mikropoulos C, Bancroft EK, Dadaev T, Goh C, Taylor N, Saunders E, Borley N, Keating D, Page EC, Saya S, Hazell S, Livni N, deSouza N, Neal D, Hamdy FC, Kumar P, Antoniou AC, Kote-Jarai Z; PROFILE Study Steering Committee, Eeles RA.

Oncologist. 2016 Jun;21(6):716-22. doi: 10.1634/theoncologist.2015-0336. Epub 2016 May 5.

14.

Two cases of gallbladder metastasis from renal cell carcinoma and review of literature.

Costa Neves M, Neofytou K, Giakoustidis A, Hazell S, Wotherspoon A, Gore M, Mudan S.

World J Surg Oncol. 2016 Mar 22;14:87. doi: 10.1186/s12957-016-0843-3.

15.

Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature Review.

Boussios S, Attygalle A, Hazell S, Moschetta M, McLachlan J, Okines A, Banerjee S.

Anticancer Res. 2015 Dec;35(12):6713-22. Review.

PMID:
26637887
16.

Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer.

Challapalli A, Trousil S, Hazell S, Kozlowski K, Gudi M, Aboagye EO, Mangar S.

J Clin Pathol. 2015 Sep;68(9):703-9. doi: 10.1136/jclinpath-2015-202859. Epub 2015 Jun 3.

PMID:
26041862
17.

Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.

Cooper CS, Eeles R, Wedge DC, Van Loo P, Gundem G, Alexandrov LB, Kremeyer B, Butler A, Lynch AG, Camacho N, Massie CE, Kay J, Luxton HJ, Edwards S, Kote-Jarai Z, Dennis N, Merson S, Leongamornlert D, Zamora J, Corbishley C, Thomas S, Nik-Zainal S, Ramakrishna M, O'Meara S, Matthews L, Clark J, Hurst R, Mithen R, Bristow RG, Boutros PC, Fraser M, Cooke S, Raine K, Jones D, Menzies A, Stebbings L, Hinton J, Teague J, McLaren S, Mudie L, Hardy C, Anderson E, Joseph O, Goody V, Robinson B, Maddison M, Gamble S, Greenman C, Berney D, Hazell S, Livni N; ICGC Prostate Group, Fisher C, Ogden C, Kumar P, Thompson A, Woodhouse C, Nicol D, Mayer E, Dudderidge T, Shah NC, Gnanapragasam V, Voet T, Campbell P, Futreal A, Easton D, Warren AY, Foster CS, Stratton MR, Whitaker HC, McDermott U, Brewer DS, Neal DE.

Nat Genet. 2015 Jun;47(6):689. doi: 10.1038/ng0615-689b. No abstract available.

18.

Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.

Kovac M, Navas C, Horswell S, Salm M, Bardella C, Rowan A, Stares M, Castro-Giner F, Fisher R, de Bruin EC, Kovacova M, Gorman M, Makino S, Williams J, Jaeger E, Jones A, Howarth K, Larkin J, Pickering L, Gore M, Nicol DL, Hazell S, Stamp G, O'Brien T, Challacombe B, Matthews N, Phillimore B, Begum S, Rabinowitz A, Varela I, Chandra A, Horsfield C, Polson A, Tran M, Bhatt R, Terracciano L, Eppenberger-Castori S, Protheroe A, Maher E, El Bahrawy M, Fleming S, Ratcliffe P, Heinimann K, Swanton C, Tomlinson I.

Nat Commun. 2015 Mar 19;6:6336. doi: 10.1038/ncomms7336.

19.

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.

Cooper CS, Eeles R, Wedge DC, Van Loo P, Gundem G, Alexandrov LB, Kremeyer B, Butler A, Lynch AG, Camacho N, Massie CE, Kay J, Luxton HJ, Edwards S, Kote-Jarai Z, Dennis N, Merson S, Leongamornlert D, Zamora J, Corbishley C, Thomas S, Nik-Zainal S, O'Meara S, Matthews L, Clark J, Hurst R, Mithen R, Bristow RG, Boutros PC, Fraser M, Cooke S, Raine K, Jones D, Menzies A, Stebbings L, Hinton J, Teague J, McLaren S, Mudie L, Hardy C, Anderson E, Joseph O, Goody V, Robinson B, Maddison M, Gamble S, Greenman C, Berney D, Hazell S, Livni N; ICGC Prostate Group, Fisher C, Ogden C, Kumar P, Thompson A, Woodhouse C, Nicol D, Mayer E, Dudderidge T, Shah NC, Gnanapragasam V, Voet T, Campbell P, Futreal A, Easton D, Warren AY, Foster CS, Stratton MR, Whitaker HC, McDermott U, Brewer DS, Neal DE.

Nat Genet. 2015 Apr;47(4):367-372. doi: 10.1038/ng.3221. Epub 2015 Mar 2. Erratum in: Nat Genet. 2015 Jun;47(6):689.

20.

Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution.

Fisher R, Horswell S, Rowan A, Salm MP, de Bruin EC, Gulati S, McGranahan N, Stares M, Gerlinger M, Varela I, Crockford A, Favero F, Quidville V, André F, Navas C, Grönroos E, Nicol D, Hazell S, Hrouda D, O'Brien T, Matthews N, Phillimore B, Begum S, Rabinowitz A, Biggs J, Bates PA, McDonald NQ, Stamp G, Spencer-Dene B, Hsieh JJ, Xu J, Pickering L, Gore M, Larkin J, Swanton C.

Genome Biol. 2014 Aug 27;15(8):433. doi: 10.1186/s13059-014-0433-z.

21.

Sarcomatoid carcinoma of the prostate: ERG fluorescence in-situ hybridization confirms epithelial origin.

Rodrigues DN, Hazell S, Miranda S, Crespo M, Fisher C, de Bono JS, Attard G.

Histopathology. 2015 May;66(6):898-901. doi: 10.1111/his.12493. Epub 2014 Nov 10. No abstract available.

PMID:
25041380
22.

Melanoma with rhabdomyosarcomatous differentiation: two further cases of a rare pathologic pitfall.

Shenjere P, Fisher C, Rajab R, Patnaik L, Hazell S, Thway K.

Int J Surg Pathol. 2014 Sep;22(6):512-9. doi: 10.1177/1066896914531817. Epub 2014 Apr 29.

PMID:
24788528
23.

Rhabdomyosarcoma with pseudolipoblasts arising in ovarian carcinosarcoma: a distinctive postchemotherapy morphologic variant mimicking pleomorphic liposarcoma.

Thway K, Hazell S, Banerjee S, Fisher C.

Case Rep Pathol. 2014;2014:238545. doi: 10.1155/2014/238545. Epub 2014 Jan 22.

24.

Preoperative imaging in patients undergoing trachelectomy for cervical cancer: validation of a combined T2- and diffusion-weighted endovaginal MRI technique at 3.0 T.

Downey K, Shepherd JH, Attygalle AD, Hazell S, Morgan VA, Giles SL, Ind TE, Desouza NM.

Gynecol Oncol. 2014 May;133(2):326-32. doi: 10.1016/j.ygyno.2014.02.026. Epub 2014 Feb 26.

25.

Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.

Sanders TJ, McCarthy NE, Giles EM, Davidson KL, Haltalli ML, Hazell S, Lindsay JO, Stagg AJ.

Gastroenterology. 2014 May;146(5):1278-88.e1-2. doi: 10.1053/j.gastro.2014.01.057. Epub 2014 Feb 4.

PMID:
24503130
26.

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.

Gerlinger M, Horswell S, Larkin J, Rowan AJ, Salm MP, Varela I, Fisher R, McGranahan N, Matthews N, Santos CR, Martinez P, Phillimore B, Begum S, Rabinowitz A, Spencer-Dene B, Gulati S, Bates PA, Stamp G, Pickering L, Gore M, Nicol DL, Hazell S, Futreal PA, Stewart A, Swanton C.

Nat Genet. 2014 Mar;46(3):225-233. doi: 10.1038/ng.2891. Epub 2014 Feb 2.

27.

Diffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk.

deSouza NM, Morgan VA, Bancroft E, Sohaib SA, Giles SL, Kote-Jarai Z, Castro E, Hazell S, Jafar M, Eeles R.

Eur J Radiol Open. 2014;1:22-27.

28.

Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.

Gerlinger M, Quezada SA, Peggs KS, Furness AJ, Fisher R, Marafioti T, Shende VH, McGranahan N, Rowan AJ, Hazell S, Hamm D, Robins HS, Pickering L, Gore M, Nicol DL, Larkin J, Swanton C.

J Pathol. 2013 Dec;231(4):424-32. doi: 10.1002/path.4284.

29.

Influencing surgical management in patients with carcinoma of the cervix using a T2- and ZOOM-diffusion-weighted endovaginal MRI technique.

Downey K, Jafar M, Attygalle AD, Hazell S, Morgan VA, Giles SL, Schmidt MA, Ind TE, Shepherd JH, deSouza NM.

Br J Cancer. 2013 Aug 6;109(3):615-22. doi: 10.1038/bjc.2013.375. Epub 2013 Jul 18.

30.
31.

Bio-activity of natural polymers from the genus Pistacia: a validated model for their antimicrobial action.

Sharifi MS, Ebrahimi D, Hibbert DB, Hook J, Hazell SL.

Glob J Health Sci. 2011 Dec 29;4(1):149-61. doi: 10.5539/gjhs.v4n1p149.

32.

Anatomically versus biologically unifocal prostate cancer: a pathological evaluation in the context of focal therapy.

Karavitakis M, Ahmed HU, Abel PD, Hazell S, Winkler MH.

Ther Adv Urol. 2012 Aug;4(4):155-60. doi: 10.1177/1756287212447092.

33.

Lymphoepithelioma-like carcinoma of the urinary bladder: A case report and review of systemic treatment options.

Pantelides NM, Ivaz SL, Falconer A, Hazell S, Winkler M, Hrouda D, Mayer EK.

Urol Ann. 2012 Jan;4(1):45-7. doi: 10.4103/0974-7796.91626.

34.

Trends in pathologic outcomes after introduction of active surveillance in the UK: implication for focal therapy.

Karavitakis M, Ahmed HU, Abel PD, Livni N, Hazell S, Winkler MH.

Prostate. 2012 Sep 15;72(13):1464-8. doi: 10.1002/pros.22498. Epub 2012 Feb 10.

PMID:
22328187
35.

Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model.

Kotiw M, Johnson M, Pandey M, Fry S, Hazell SL, Netter HJ, Good MF, Olive C.

Clin Vaccine Immunol. 2012 Feb;19(2):268-76. doi: 10.1128/CVI.05295-11. Epub 2011 Dec 28.

36.

Margin status after laparoscopic radical prostatectomy and the index lesion: implications for preoperative evaluation of tumor focality in prostate cancer.

Karavitakis M, Ahmed HU, Abel PD, Hazell S, Winkler MH.

J Endourol. 2012 May;26(5):503-8. doi: 10.1089/end.2011.0345. Epub 2012 Feb 8.

PMID:
22142404
37.

Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.

Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S, Tomasi G, Al-Nahhas A, Mapelli P, Kenny LM, Tadrous P, Coombes RC, Aboagye EO, Mangar S.

Clin Cancer Res. 2011 Dec 15;17(24):7673-83. doi: 10.1158/1078-0432.CCR-11-2048. Epub 2011 Oct 28.

38.

Focal therapy for prostate cancer: opportunities and uncertainties.

Karavitakis M, Winkler MH, Abel PD, Hazell S, Ahmed HU.

Discov Med. 2011 Sep;12(64):245-55. Review.

39.

Low temperature thresholds: are chill coma and CT(min) synonymous?

Hazell SP, Bale JS.

J Insect Physiol. 2011 Aug;57(8):1085-9. doi: 10.1016/j.jinsphys.2011.04.004. Epub 2011 Apr 9. Review.

PMID:
21510951
40.

Antibiotic Susceptibility and Resistance.

Mégraud F, Hazell S, Glupczynski Y.

In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: Physiology and Genetics. Washington (DC): ASM Press; 2001. Chapter 42.

41.

Evasion of the Toxic Effects of Oxygen.

Hazell SL, Harris AG, Trend MA.

In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: Physiology and Genetics. Washington (DC): ASM Press; 2001. Chapter 15.

42.

Overview.

Mobley HLT, Mendz GL, Hazell SL.

In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: Physiology and Genetics. Washington (DC): ASM Press; 2001. Chapter 1.

43.

Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromes.

Murphy SM, Khan U, Alifrangis C, Hazell S, Hrouda D, Blake J, Ball J, Gabriel C, Markarian P, Rees J, Karim A, Seckl MJ, Lunn MP, Reilly MM.

J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):232-3. doi: 10.1136/jnnp.2010.223271. Epub 2011 Jan 4. No abstract available.

44.

Tumor focality in prostate cancer: implications for focal therapy.

Karavitakis M, Ahmed HU, Abel PD, Hazell S, Winkler MH.

Nat Rev Clin Oncol. 2011 Jan;8(1):48-55. doi: 10.1038/nrclinonc.2010.190. Epub 2010 Nov 23. Review.

PMID:
21116296
45.

Hyperthermic aphids: insights into behaviour and mortality.

Hazell SP, Neve BP, Groutides C, Douglas AE, Blackburn TM, Bale JS.

J Insect Physiol. 2010 Feb;56(2):123-31. doi: 10.1016/j.jinsphys.2009.08.022. Epub 2009 Sep 12.

PMID:
19737571
46.

A comparison of low temperature tolerance traits between closely related aphids from the tropics, temperate zone, and Arctic.

Hazell SP, Groutides C, Neve BP, Blackburn TM, Bale JS.

J Insect Physiol. 2010 Feb;56(2):115-22. doi: 10.1016/j.jinsphys.2009.08.020. Epub 2009 Sep 6.

PMID:
19723528
47.

Fractionation of Mastic Gum in Relation to Antimicrobial Activity.

Sharif Sharifi M, Hazell SL.

Pharmaceuticals (Basel). 2009 Apr 1;2(1):2-10.

48.

Detection of HSV type-1 and type-2 IgG using an in vitro PCA based homogeneous immunoassay.

Fry SR, Li J, de las Heras R, McCourt JA, Arel E, Kachab EH, Hazell SL, Huang CY.

Biochem Biophys Res Commun. 2008 Aug 8;372(4):542-6. doi: 10.1016/j.bbrc.2008.05.075. Epub 2008 May 27.

PMID:
18503749
49.

Development of homogeneous immunoassays based on protein fragment complementation.

de las Heras R, Fry SR, Li J, Arel E, Kachab EH, Hazell SL, Huang CY.

Biochem Biophys Res Commun. 2008 May 23;370(1):164-8. doi: 10.1016/j.bbrc.2008.03.057. Epub 2008 Mar 19.

PMID:
18358235
50.

Clinical utility of avidity assays.

Hazell SL.

Expert Opin Med Diagn. 2007 Dec;1(4):511-9. doi: 10.1517/17530059.1.4.511.

PMID:
23496357

Supplemental Content

Loading ...
Support Center